<h3>在 TipRanks 上享受 30% 的折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级为市场领袖的投资组合，使用智能投资者精选</li>
</ul>
<p>先健科技（LifeTech Scientific Corporation）(HK:1302) 提供了最新动态。</p>
<p>先健科技是一家在开曼群岛注册并在香港上市的公司，其董事会由执行董事、非执行董事和独立非执行董事组成，这些董事还在审计、提名和薪酬委员会任职。该公司遵守香港上市规则的合规性取决于在这些委员会中保持足够的独立代表，以确保适当的公司治理和监管监督。</p>
<p>在一名独立非执行董事辞职后，先健科技未能满足独立董事会和委员会成员的最低要求，并且在规定的三个月宽限期内未能填补该空缺。公司进行了广泛的搜索，但现在寻求来自证券交易所的豁免和延期，以恢复合规，承诺继续努力任命合适的候选人，并誓言在治理缺口解决后及时向市场更新情况。</p>
<p>任命替代者的延迟突显了寻找符合监管标准和董事会需求的合格独立董事的挑战，强调了对较小发行人的治理压力。在填补空缺和获得监管豁免（如有）之前，利益相关者面临公司在上市治理要求方面的正式合规性处于过渡期，尽管董事会表示其意图尽快纠正这一情况。</p>
<p><strong>关于先健科技的更多信息</strong></p>
<p>先健科技是一家在开曼群岛注册并在香港上市的公司，通过一个集团结构运营，董事会由执行董事、非执行董事和独立非执行董事组成。该集团受香港上市规则的约束，涉及董事会组成和关键治理委员会的结构，包括审计、提名和薪酬委员会。</p>
<p>公司的治理框架依赖于保持足够数量的独立非执行董事来担任和填补这些委员会，确保合规和监督。最近的董事会变动触发了多个上市规则下的义务，要求及时任命以恢复董事会及其委员会上独立监督的强制性平衡。</p>
<p><strong>平均交易量：</strong> 17,589,817</p>
<p><strong>技术情绪信号：</strong> 买入</p>
<p><strong>当前市值：</strong> HK$8.12B</p>

先健科技

<p>生命科技公司正在寻求香港证券交易所的延期，以恢复对香港上市规则的合规性，因为由于一名独立非执行董事的辞职，该公司未能满足独立董事代表的最低要求。该公司在三个月的宽限期内未能填补该空缺，并面临寻找合格候选人的挑战。生命科技承诺将继续努力任命合适的候选人，并将在治理缺口得到解决后向市场更新信息，突显出对较小发行人的持续治理压力</p>

<h3>Claim 30% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 30% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级为市场领袖的投资组合，使用智能投资者精选</li>
</ul>
</div><p>LifeTech Scientific Corporation ( (HK:1302) ) has provided an update.</p>
<div class="lb-trans"><p>先健科技（LifeTech Scientific Corporation）(HK:1302) 提供了最新动态。</p>
</div><p>LifeTech Scientific Corporation, a Cayman Islands-incorporated issuer listed in Hong Kong, is governed by a board that includes executive, non-executive and independent non-executive directors, who also serve on the audit, nomination and remuneration committees. The company’s compliance with Hong Kong Listing Rules depends on maintaining adequate independent representation on these committees to ensure appropriate corporate governance and regulatory oversight.</p>
<div class="lb-trans"><p>先健科技是一家在开曼群岛注册并在香港上市的公司，其董事会由执行董事、非执行董事和独立非执行董事组成，这些董事还在审计、提名和薪酬委员会任职。该公司遵守香港上市规则的合规性取决于在这些委员会中保持足够的独立代表，以确保适当的公司治理和监管监督。</p>
</div><p>Following the resignation of an independent non-executive director, LifeTech has fallen below the minimum requirements for independent board and committee membership and has been unable to fill the vacancy within the prescribed three‑month grace period. The company has conducted an extensive search but now seeks a waiver and an extension from the Stock Exchange to regain compliance, pledging continued efforts to appoint a suitable candidate and vowing to update the market once the governance gaps are resolved.</p>
<div class="lb-trans"><p>在一名独立非执行董事辞职后，先健科技未能满足独立董事会和委员会成员的最低要求，并且在规定的三个月宽限期内未能填补该空缺。公司进行了广泛的搜索，但现在寻求来自证券交易所的豁免和延期，以恢复合规，承诺继续努力任命合适的候选人，并誓言在治理缺口解决后及时向市场更新情况。</p>
</div><p>The delay in appointing a replacement underscores the challenges of sourcing qualified independent directors who meet regulatory standards and board needs, highlighting governance pressures on smaller issuers. Until the vacancy is filled and regulatory waivers, if any, are granted, stakeholders face a period in which the company’s formal compliance with listing governance requirements remains in transition, although the board signals its intention to rectify the situation as soon as practicable.</p>
<div class="lb-trans"><p>任命替代者的延迟突显了寻找符合监管标准和董事会需求的合格独立董事的挑战，强调了对较小发行人的治理压力。在填补空缺和获得监管豁免（如有）之前，利益相关者面临公司在上市治理要求方面的正式合规性处于过渡期，尽管董事会表示其意图尽快纠正这一情况。</p>
</div><p><strong>More about LifeTech Scientific Corporation</strong></p>
<div class="lb-trans"><p><strong>关于先健科技的更多信息</strong></p>
</div><p>LifeTech Scientific Corporation is a Cayman Islands-incorporated company listed in Hong Kong that operates through a group structure, overseen by a board comprising executive, non-executive and independent non-executive directors. The group is subject to Hong Kong Listing Rules governing board composition and the structure of key governance committees, including audit, nomination and remuneration committees.</p>
<div class="lb-trans"><p>先健科技是一家在开曼群岛注册并在香港上市的公司，通过一个集团结构运营，董事会由执行董事、非执行董事和独立非执行董事组成。该集团受香港上市规则的约束，涉及董事会组成和关键治理委员会的结构，包括审计、提名和薪酬委员会。</p>
</div><p>The company’s governance framework relies on maintaining a sufficient number of independent non-executive directors to chair and populate these committees, ensuring regulatory compliance and oversight. Recent board changes have triggered obligations under multiple Listing Rules, requiring timely appointments to restore the mandated balance of independent oversight on the board and its committees.</p>
<div class="lb-trans"><p>公司的治理框架依赖于保持足够数量的独立非执行董事来担任和填补这些委员会，确保合规和监督。最近的董事会变动触发了多个上市规则下的义务，要求及时任命以恢复董事会及其委员会上独立监督的强制性平衡。</p>
</div><p><strong>Average Trading Volume:</strong> 17,589,817</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 17,589,817</p>
</div><p><strong>Technical Sentiment Signal:</strong> Buy</p>
<div class="lb-trans"><p><strong>技术情绪信号：</strong> 买入</p>
</div><p><strong>Current Market Cap:</strong> HK$8.12B</p>
<div class="lb-trans"><p><strong>当前市值：</strong> HK$8.12B</p>
</div>

先健科技寻求更多时间以恢复独立董事会的合规性